Discover the fascinating world of DIY with our step-by-step guide on "How to Make a Generator." In this exciting tutorial, learn the secrets behind creating an amazing homemade generator from scratch.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) ...
A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key secondary endpoints. Yet, with the data falling short of analyst expectations, shares in the company opened down 9% ...
This persnickety number determines the strength of magnetic fields. It figures in everything from motors and generators to audio speakers. Oh, and without it we’d live in eternal darkness.
How early trial-and-error methods gave way to modern tri-sodium phosphate programs, and why chemistry control remains ...
The current Alzheimer’s disease therapeutic antibodies carry a sizable risk of ARIA, especially for APOE4 carriers. Researchers believe the future of amyloid immunotherapies lies in targeted brain ...
In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines Participants with obesity or ...
A dive into the engineering behind Tektronix's new 7 Series 4-ch. scope featuring 25-GHz bandwidth, 125-Gsample/s rate, world ...
If transportation large models merely generate dense traffic flow heat maps, they have turned transportation into a 'moving PowerPoint presentation.' What urban managers truly need is not ...
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results